Breast Cancer Clinical Trial

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

Summary

The majority pf breast cancers present as ER-positive, many of which are able to be targeted with multiple hormonal therapies. Altering ER-negative tumors to increase ER expression has the potential to benefit patients by making hormonal therapies a therapeutic option and possibly improving their overall prognosis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women who have Her-2 positive and ER- negative or ER-low breast cancer that has not metastasized, or spread to other parts of the body, are eligible for the study.
Participants must have had either a core biopsy or incisional biopsy of their breast cancer, but not yet had definitive breast surgery, including lumpectomy or mastectomy.
Participants may not have had a BRCA mutation found on genetic testing.

Participants should have not yet received treatment for their breast cancer, including:

chemotherapy,
hormonal therapy,
trastuzumab.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

1

Study ID:

NCT00726180

Recruitment Status:

Terminated

Sponsor:

University of Michigan Rogel Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Comprehensive Cancer Center
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

1

Study ID:

NCT00726180

Recruitment Status:

Terminated

Sponsor:


University of Michigan Rogel Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider